Navigation Links
Drugs to Tackle Anemia may Be Playing Dracula

The FDA has issued the ‘black box’ warning- the highest level of warning, to the genetically engineered drugs, erythtropoietins//, that are meant to counteract anemia.

These drugs, such as Epo, are given to patients suffering from anemia caused by chemotherapy and kidney failure. They are hormone-based drugs, usually derived from kidneys.

It was seen that there was a more than a warranted number of complications such as blood clots, strokes heart attacks and even early death arising from over use of the drug. This was seen especially in patients with chronic kidney failure.

These drugs are among the top 3 selling drugs in the U.S and major producers Amgen and Johnson and Johnson reported record sales of 10 billion dollars last year.

The drugs are advertised directly to consumers, even though they are extremely expensive and given only by injection.

Recent studies suggest that the drugs, which are commonly prescribed to cancer patients receiving chemotherapy, may actually make tumors grow faster and increase the risk of death, if given in high doses. This is according to the FDA’s official Richard Pazdur, who announced the new "black box' warning.

The ‘black box’ warning cautions that the drugs should be used at the lowest dose necessary to avoid the need for a blood transfusion. They should not be used to fully reverse anemia.

The FDA’s public health advisory yesterday could now mean that physicians are likely to be more light-handed in their use of these drugs.

'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Breast Cancer Conference from Sept. 18 to 20. , The two-day conference is ... subtype with the goal of improving patients’ lives and eliminating racial breast cancer-related ...
(Date:6/23/2017)... Monica, CA (PRWEB) , ... June 23, 2017 , ... ... as the endorsed amalgam separator supplier for CDA members. As part of the amalgam ... reduced price of $99, saving more than $400 off the retail value. This partnership ...
(Date:6/23/2017)... San Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... Conference on 26th June, 2017 from 9 am to 3 pm to present to ... curriculum. The program is an original curriculum project led by The Health Improvement ...
(Date:6/23/2017)... Gilmer, TX (PRWEB) , ... June 23, 2017 , ... ... consultations to residential and business clients throughout eastern Texas, is announcing the launch of ... , Recent breast cancer statistics in the United States reveal that an estimated ...
(Date:6/22/2017)... Miami, FL (PRWEB) , ... June 22, 2017 , ... ... has received more than $245,000 in grant funding to support its programs focused on ... recently, Branches, Inc. was awarded a grant by the Foundation of $15,000 to support ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)...  Novavax, Inc., (Nasdaq: NVAX ) today announced ... of its RSV F protein recombinant nanoparticle vaccine candidate (RSV ... published in the journal Vaccine (the ... scientific conferences). The Company previously announced top line results ... the RSV F Vaccine with the goal of protecting infants ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq: ... care, today announced new findings demonstrating positive biochemical outcomes ... System One™. The data will be presented at ... Madrid, Spain . ... Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)...  Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: ... functional selection of stem cells, today provided a corporate ... ended March 31 st , 2017. ... first quarter of 2017," said Dr. Shai Yarkoni, Chief ... treatment of the first blood cancer patient in the ...
Breaking Medicine Technology: